Researchers determined a short duration of anticoagulation therapy could be beneficial in comparison to a longer course for primary treatment VTE.

Heightened interest in left ventricular thrombus (LVT) stems from the consistent association of subsequent stroke and ...

Positive Phase 2 results indicate that REGN7508 and REGN9933 demonstrated robust antithrombotic effects without clinically relevant bleeding, showcasing safety and efficacy for potential future use.

Regeneron anticoagulant bests enoxaparin, matches Eliquis in phase 2 trial By James Waldron Dec 19, 2024 8:50am Regeneron Pharmaceuticals anticoagulant Clinical Data ...

Source Reference: Cho MS, et al "Edoxaban antithrombotic therapy for atrial fibrillation and stable coronary artery disease" N Engl J Med 2024; DOI: 10.1056/NEJMoa2407362.

The study included 250 patients (antithrombotic agent nonusers, 42.0%; oral anticoagulant users, 34.0%; and antiplatelet users, 24.0%). The primary outcomes did not differ among the 3 groups. Among ...

There are two classes of antithrombotic drugs that can prevent this, anticoagulants and antiplatelet agents. Anticoagulants slow clotting through action on enzymes involved in the clot formation ...

The frequency of intracranial hemorrhage after ground-level fall with good neurological status was not significantly different between patients on antithrombotic therapy and those not on ...

The ACG and Canadian Association of Gastroenterology have developed recommendations for the management of anticoagulants and antiplatelets during acute gastrointestinal bleeding and the elective ...

"Anticoagulants help moderately ill COVID-19 patients, study finds." ScienceDaily. ScienceDaily, 20 August 2021. <www.sciencedaily.com / releases / 2021 / 08 / 210820093357.htm>.